Ken Griffin Artivion, Inc. Transaction History

Citadel Advisors LLC

$505 Billion
Q3 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Artivion, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 20,500 shares of AORT stock, worth $547,145. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,500

Previous 5,900 247.46%

Holding current value

$547,145

Previous $151,000 260.93%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$24.33 - $28.46 $486,016 - $568,516	-19,976 Reduced 43.65%	25,790 $686,000
Q2 2024 Aug 14, 2024	SELL	$19.62 - $25.65 $1.23 Million - $1.61 Million	-62,899 Reduced 57.88%	45,766 $1.17 Million
Q1 2024 May 15, 2024	BUY	$16.7 - $21.63 $818,283 - $1.06 Million	48,999 Added 82.12%	108,665 $2.3 Million
Q4 2023 Feb 14, 2024	SELL	$12.33 - $18.83 $34,893 - $53,288	-2,830 Reduced 4.53%	59,666 $1.07 Million
Q3 2023 Nov 14, 2023	SELL	$14.82 - $17.52 $444,007 - $524,899	-29,960 Reduced 32.4%	62,496 $947,000
Q2 2023 Aug 14, 2023	BUY	$12.78 - $17.23 $658,936 - $888,378	51,560 Added 126.08%	92,456 $1.59 Million
Q1 2023 May 15, 2023	SELL	$11.74 - $14.12 $1.67 Million - $2.01 Million	-142,633 Reduced 77.72%	40,896 $535,000
Q4 2022 Feb 14, 2023	BUY	$10.01 - $13.9 $966,415 - $1.34 Million	96,545 Added 110.99%	183,529 $2.22 Million
Q3 2022 Nov 14, 2022	BUY	$13.31 - $23.25 $782,734 - $1.37 Million	58,808 Added 208.72%	86,984 $1.2 Million
Q2 2022 Aug 15, 2022	BUY	$15.73 - $22.91 $42,140 - $61,375	2,679 Added 10.51%	28,176 $532,000
Q1 2022 May 16, 2022	SELL	$16.95 - $21.74 $421,190 - $540,217	-24,849 Reduced 49.36%	25,497 $545,000
Q4 2021 Feb 14, 2022	SELL	$17.19 - $22.84 $756,910 - $1.01 Million	-44,032 Reduced 46.65%	50,346 $1.02 Million
Q3 2021 Nov 15, 2021	BUY	$22.29 - $28.7 $821,609 - $1.06 Million	36,860 Added 64.08%	94,378 $2.1 Million
Q2 2021 Aug 16, 2021	BUY	$22.32 - $32.07 $713,748 - $1.03 Million	31,978 Added 125.21%	57,518 $1.63 Million
Q4 2020 Feb 16, 2021	SELL	$16.76 - $23.74 $3.03 Million - $4.29 Million	-180,537 Reduced 87.61%	25,540 $603,000
Q3 2020 Nov 16, 2020	BUY	$16.35 - $21.4 $2.98 Million - $3.9 Million	182,140 Added 760.91%	206,077 $3.81 Million
Q1 2020 May 15, 2020	SELL	$14.66 - $30.57 $319,969 - $667,220	-21,826 Reduced 47.69%	23,937 $405,000
Q4 2019 Feb 14, 2020	BUY	$22.45 - $27.09 $43,463 - $52,446	1,936 Added 4.42%	45,763 $1.24 Million
Q2 2019 Aug 14, 2019	BUY	$27.55 - $32.39 $986,813 - $1.16 Million	35,819 Added 447.29%	43,827 $1.31 Million
Q1 2019 May 15, 2019	SELL	$25.85 - $30.47 $89,415 - $105,395	-3,459 Reduced 30.16%	8,008 $0
Q4 2018 Feb 14, 2019	SELL	$25.76 - $34.03 $667,158 - $881,342	-25,899 Reduced 69.31%	11,467 $325,000
Q2 2018 Aug 10, 2018	BUY	$19.4 - $29.35 $180,342 - $272,837	9,296 Added 33.12%	37,366 $0
Q1 2018 May 11, 2018	SELL	$16.85 - $22.1 $146,207 - $191,761	-8,677 Reduced 23.61%	28,070 $563,000
Q4 2017 Feb 09, 2018	BUY	$18.65 - $23.85 $685,331 - $876,415	36,747	36,747 $704,000

Others Institutions Holding AORT

# of Institutions

175

Shares Held

36M

Call Options Held

33K

Put Options Held

900

View Full List

About ARTIVION, INC.

Ticker AORT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 40,316,100
Market Cap $1.08B
Description
Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...

More about AORT

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account